Showing 2 of 10 years of data. Sign up free for 3 years, or upgrade for full access.
View PlansCash Conversion
0.97x
AJANTPHARM's operating cash flow covered 97% of net income in FY 2025. Some earnings may be tied up in working capital.
Free Cash Flow
₹8.39B
AJANTPHARM's free cash flow was ₹8.39B in FY 2025, up 32.7% from FY 2024.
Dividend Coverage
2.4x
AJANTPHARM's free cash flow covered dividends 2.4x in FY 2025, leaving room for reinvestment or debt reduction.
CapEx Intensity
27.5%
Capital expenditure was 27.5% of operating cash flow in FY 2025 for AJANTPHARM, indicating a capital-light business.
Hover the chart icon for YoY change.
| Item | Chart | 2024 | 2025 |
|---|---|---|---|
| Net Income | 11.14B | 11.89B | |
| Cash flow Operating Activities | 7.85B | 11.57B | |
| Investments in PPE | -1.52B | -3.18B | |
| Cash flow Investing Activities | 653.90M | -3.77B | |
| Dividend Paid | -6.42B | -3.49B | |
| Cash flow Financing Activities | -10.51B | -7.33B | |
| Cash at beginning of period | 3.30B | 1.29B | |
| Cash at end of period | 1.29B | 1.77B | |
| Free Cash Flow | 6.33B | 8.39B |
Values are shown in millions (M) and billions (B). All amounts are in Indian Rupees (₹).
Data from audited consolidated filings. For educational purposes only — not investment advice. Last update: Mar-2025